Literature DB >> 15935933

Neonatal antecedents for cerebral palsy in extremely preterm babies and interaction with maternal factors.

Uyen Tran1, Peter H Gray, Michael J O'Callaghan.   

Abstract

BACKGROUND: Preterm delivery is associated with an increased risk of cerebral palsy (CP). The greatest risk is for infants born <28 weeks' gestation. AIMS: To identify significant neonatal risk factors for CP and explore the interactions between antenatal and neonatal risk factors, among extremely preterm infants of 27 weeks' gestation or less. STUDY
DESIGN: Nested case control design.
METHODS: Infants born between 1989 and 1996, at 24-27 weeks' gestation, were evaluated: 30 with CP at 2 years corrected age and 120 control infants matched for gestation age. Neonatal variables were compared using matched analyses with the interaction between antenatal and neonatal factors being examined using logistic regression analyses.
RESULTS: Risk factors for CP on matched analyses included patent ductus arteriosus requiring surgical ligation, peri-intraventricular haemorrhage, moderate to severe ventricular dilatation, periventricular leukomalacia (PVL) and need for home oxygen. Independent neonatal predictors were ventricular dilatation (OR 7.3; 95% CI 1.6, 32.3), PVL (OR 29.8; 95% CI 5.6, 159.1) and home oxygen use (OR 3.4; 95% CI 1.2, 9.4). No interaction terms in the logistic models were significant between the previously identified pregnancy risk factors of absence of antenatal steroids and intrauterine growth restriction and the neonatal risk factors.
CONCLUSIONS: PVL is the most powerful independent predictor of CP in extremely preterm infants of 27 weeks' gestation or less and appears to be uninfluenced by antenatal factors.

Entities:  

Mesh:

Year:  2005        PMID: 15935933     DOI: 10.1016/j.earlhumdev.2004.12.009

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Authors:  Jeff Reese; Matthew M Laughon
Journal:  J Pediatr       Date:  2015-08-24       Impact factor: 4.406

2.  At-Home Orthodontic Treatment for Severe Teeth Arch Malalignment and Severe Obstructive Sleep Apnea Syndrome in a Child with Cerebral Palsy.

Authors:  Atsuko Tamura; Kohei Yamaguchi; Ryosuke Yanagida; Rie Miyata; Haruka Tohara
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

3.  Association of cerebral palsy with Apgar score in low and normal birthweight infants: population based cohort study.

Authors:  Kari Kveim Lie; Else-Karin Grøholt; Anne Eskild
Journal:  BMJ       Date:  2010-10-06

4.  Severe gyration and migration disorder in fetofetal transfusion syndrome: two case reports and a review of the literature on the neurological outcome of children with lesions on neuroimaging.

Authors:  Rudolf Ascherl; Ina Sorge; Ulrich Thome; Franz Wolfgang Hirsch; Annett Bläser; Wieland Kiess; Andreas Merkenschlager
Journal:  Childs Nerv Syst       Date:  2017-10-02       Impact factor: 1.475

5.  ''Intraventricular'' hemorrhage and cystic periventricular leukomalacia in preterm infants: how are they related?

Authors:  Cynthia D J Kusters; Minghua L Chen; Pamela L Follett; Olaf Dammann
Journal:  J Child Neurol       Date:  2009-09       Impact factor: 1.987

6.  Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews.

Authors:  Emily Shepherd; Rehana A Salam; Philippa Middleton; Shanshan Han; Maria Makrides; Sarah McIntyre; Nadia Badawi; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2018-06-20

Review 7.  Association between bronchopulmonary dysplasia and cerebral palsy in children: a meta-analysis.

Authors:  Xiaoyun Gou; Lei Yang; Lingli Pan; Dongqiong Xiao
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

Review 8.  SGA as a Risk Factor for Cerebral Palsy in Moderate to Late Preterm Infants: a System Review and Meta-analysis.

Authors:  Mengwen Zhao; Hongmei Dai; Yuanying Deng; Lingling Zhao
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.